Dr. Howard Fein, MD

Dr. Fein practices at Emanuel Medical Center in Turlock, California, part of Tenet Healthcare.

Dr. Fein's NPI, 1184707838, was assigned on October 23, 2006. Dr. Fein graduated from Keck School of Medicine of USC in 1998. Dr. Fein holds California license A84759.

Dr. Fein's primary practice is Emanuel Medical Center, at 825 Delbon Ave, Turlock, CA 95382 in Stanislaus County. The practice phone is (209) 667-4200.

Dr. Fein's primary practice is Emanuel Medical Center in Turlock, California, part of Tenet Healthcare. Dr. Fein is also affiliated with Torrance Memorial Medical Center. The medical group on file is Pacific Dermatology Specialists. Dmand AI also links Dr. Fein to 2 more group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fein practices, 5 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Fein's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Fein is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Fein's licenses on file in 6 states: California, Florida, New York, Virginia, Illinois and Ohio.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes and joint cyst among the conditions Dr. Fein treats.

CMS data shows 12,345 Medicare services from Dr. Fein across 43 procedure codes in 2024, for 876 Medicare patients. Medicare paid $2,051,591 for them. Every service was in an office.

CMS counts 876 Medicare patients who saw Dr. Fein in 2024. The largest group is 75 to 84, with 386 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fein's median patient age at 63, with 52% women.

In 2024, Dr. Fein wrote 1,053 Medicare Part D claims for 379 patients. 93% of them were for generic drugs. CMS names the drug for 932 of them, across 19 drugs with 11 or more claims each, at $156,522 in total drug cost. In 2023, CMS named 846 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Fein for performance year 2024, reported as part of a group. Dr. Fein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,486 procedures of removal of skin lesions by Dr. Fein, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Fein.

Dmand AI links Dr. Fein to 1 clinical trial. Conditions studied include Acneiform Eruptions and Acne Vulgaris.

CMS Open Payments shows 524 general payments to Dr. Fein from 41 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. Incyte Corporation paid the most, $13,883.

Dmand AI lists 3 awards for Dr. Fein, most recently CMS Stage 1 EHR in 2013.

Dr. Fein graduated from Keck School of Medicine of USC in 1998. Dr. Fein is a member of AAD and ASDS.

Dr. Fein is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.